<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
COLORADO MEDTECH, INC.
----------------------
(Name of Issuer)
Common Stock, No Par Value
--------------------------
Title of Class of Securities
19652U 10 4
------------
(CUSIP Number)
Jill L. Force, Senior Vice President and General Counsel, Vencor, Inc., 3300
Aegon Center, 400 West Market Street, Louisville, Kentucky 40202 (502) 596-7300
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
November 3, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See 240.13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 19652U 10 4 SCHEDULE 13D Page 2 of 9 Pages
- --------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS Vencor, Inc.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
61-1323993
- -------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
-----
(b) X
-----
- -------------------------------------------------------------------------------
3. SEC USE ONLY
- -------------------------------------------------------------------------------
4. SOURCE OF FUNDS
Not applicable.
- -------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)
Not applicable.
- -------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY (7) SOLE VOTING POWER
OWNED BY EACH REPORTING PERSON -0-
WITH
(8) SHARED VOTING POWER
-0-
(9) SOLE DISPOSITIVE POWER
-0-
(10) SHARED DISPOSITIVE POWER
-0-
- -------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON -0-
- -------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See instructions)
Not applicable
- -------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
-0-
- -------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See instructions)
HC
<PAGE>
CUSIP No. 19652U 10 4 SCHEDULE 13D Page 3 of 9 Pages
- --------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS Vencor Operating, Inc.
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
52-2085484
-------------------------------------------------------------------------------
. (CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
-----
(b) X
-----
- -------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
Not applicable
- --------------------------------------------------------------------------------
5. CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)
Not applicable.
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY (7) SOLE VOTING POWER
OWNED BY EACH REPORTING PERSON -0-
WITH
(8) SHARED VOTING POWER
-0-
(9) SOLE DISPOSITIVE POWER
-0-
(10) SHARED DISPOSITIVE POWER
-0-
- -------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON -0-
- -------------------------------------------------------------------------------
12. CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See instructions)
Not applicable
- -------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
-0-
- -------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON (See instructions)
CO
<PAGE>
CUSIP No. 19652U 10 4 Page 4 of 9 Pages
AMENDMENT NO. 2
TO
SCHEDULE 13D
OF VENCOR, INC.
This Amendment No. 2 amends and supplements the Statement on Schedule 13D,
dated April 30, 1998, and Amendment No. 1 to Schedule 13D dated September 30,
1998 filed by Vencor, Inc. and Vencor Operating, Inc., with respect to the
common stock, no par value per share, of Colorado MEDtech, Inc. (the "Amendment
No. 2"). Such Schedule 13D is hereby amended to add or replace information as
specified below to the items indicated. This Amendment No. 2 is being filed to
indicate that the Reporting Persons no longer own beneficially any securities of
the Issuer.
ITEM 1. SECURITY AND ISSUER.
--------------------
This Amendment relates to shares of common stock, no par value per share (the
"Common Stock"), of Colorado MEDtech, Inc. ("Issuer"). The principal executive
offices of the Issuer are located at 6175 Longbow Drive, Boulder, Colorado
80301.
ITEM 2. IDENTITY AND BACKGROUND.
------------------------
(a) This Amendment No. 2 is being filed by Vencor, Inc., a Delaware
corporation ("Vencor") and Vencor Operating, Inc., a Delaware corporation
("Vencor Operating") (collectively, the "Reporting Persons"). Vencor Operating
is a wholly owned subsidiary of Vencor.
(b) The address of the principal business and the principal office of each of
Vencor and Vencor Operating is 3300 Aegon Center, 400 West Market Street,
Louisville, Kentucky 40202. The principal business of Vencor and Vencor
Operating is the operation of long-term hospitals, nursing centers and other
ancillary services.
(c) The name, business address, principal occupation or employment of each
director and executive officer of Vencor is set forth in the table below.
OFFICE AND
NAME PRINCIPAL OCCUPATION BUSINESS ADDRESS
----- -------------------- ----------------
W. Bruce Lunsford Chairman of the Board 3300 Aegon Center
and Chief Executive Officer 400 West Market Street
of Vencor Louisville, KY 40202
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 19652U 10 4 Page 5 of 9 Pages
<S> <C> <C>
Edward L. Kuntz Director, President and Chief 3300 Aegon Center
Operating Officer of Vencor 400 West Market Street
Louisville, KY 40202
Richard A. Schweinhart Chief Financial Officer and 3300 Aegon Center
Senior Vice President of Vencor 400 West Market Street
Louisville, KY 40202
Richard E. Chapman Senior Vice President and Chief 3300 Aegon Center
Information Officer 400 West Market Street
Louisville, KY 40202
Jill L. Force Senior Vice President and General 3300 Aegon Center
Counsel of Vencor 400 West Market Street
Louisville, KY 40202
James H. Gillenwater, Jr. Senior Vice President, Planning 3300 Aegon Center
and Development of Vencor 400 West Market Street
Louisville, KY 40202
Richard A. Lechleiter Vice President of Finance and 3300 Aegon Center
Corporate Controller of Vencor 400 West Market Street
Louisville, KY 40202
Ulysses L. Bridgeman, Jr. President of Bridgeman Foods, 12910 Shelbyville Road
Inc., a franchisee of Wendy's Old Suite 104
Fashioned Hamburger Restaurants; Louisville, KY 40243
Director of Vencor
Elaine L. Chao Distinguished Fellow of The 214 Massachusetts Ave., NE
Heritage Foundation; Director of Washington, DC 20002-4999
Vencor
Donna R. Ecton Former Chief Operating Officer of 5602 East Via Buena Vista
PETsMART, Inc., a pet supplies Paradise Valley, AZ 85253
retailer; Director of Vencor
Stanley C. Gault Retired Chairman and Chief 1147 Akron Road
Executive Officer of the Goodyear Wooster, OH 44691-6000
Tire & Rubber Company; Director
of Vencor
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 19652U 10 4 Page 6 of 9 Pages
<S> <C> <C>
William H. Lomicka President of Mayfair Capital, 2510 Aegon Center
Inc., a private investment firm; 400 West Market Street
Director of Vencor Louisville, KY 40202
R. Gene Smith Chairman of the Board of Taco 3600 National City Tower
Tico, Inc., an operator of 101 South Fifth Street
Mexican fast-food restaurants; Louisville, KY 40202
President of New Jersey
Blockbuster, Ltd., holder of
Blockbuster Video franchises from
1987 through 1995; Managing
General Partner of Direct
Programming Services, a provider
of direct broadcast satellite
television services since 1993;
Director and Vice Chairman of
Vencor
</TABLE>
The name, business address, principal occupation or employment of each
director and executive officer of Vencor Operating is set forth in the table
below.
<TABLE>
<CAPTION>
OFFICE AND
NAME PRINCIPAL OCCUPATION BUSINESS ADDRESS
---- -------------------- ----------------
<S> <C> <C>
Edward L. Kuntz President and Chief Operating 3300 Aegon Center
Officer of Vencor Operating. Mr. 400 West Market Street
Kuntz's principal occupation is Louisville, KY 40202
Director, President and Chief
Operating Officer of Vencor
Jill L. Force Senior Vice President and General 3300 Aegon Center
Counsel of Vencor Operating. Ms. 400 West Market Street
Force's principal occupation is Louisville, KY 40202
Senior Vice President and General
Counsel of Vencor
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
CUSIP No. 19652U 10 4 Page 7 of 9 Pages
<S> <C> <C>
Richard E. Chapman Senior Vice President and Chief 3300 Aegon Center
Information Officer of Vencor 400 West Market Street
Operating. Mr. Chapman's Louisville, KY 40202
principal occupation is Senior
Vice President and Chief
Information Officer of Vencor.
James H. Gillenwater, Jr. Senior Vice President of Planning 3300 Aegon Center
and Development 400 West Market Street
of Vencor Operating. Mr. Louisville, KY 40202
Gillenwater's principal
occupation is Senior Vice
President, Planning and
Development of Vencor
Richard A. Lechleiter Vice President of Finance and 3300 Aegon Center
Corporate Controller of Vencor 400 West Market Street
Operating. Mr. Lechleiter's Louisville, KY 40202
principal occupation is Vice
President of Finance and
Corporate Controller of Vencor
W. Bruce Lunsford Chairman of the Board and Chief 3300 Aegon Center
Executive Officer of Vencor 400 West Market Street
Operating. Mr. Lunsford's Louisville, KY 40202
principal occupation is Chairman
of the Board and Chief Executive
Officer of Vencor
Richard A. Schweinhart Chief Financial Officer and 3300 Aegon Center
Senior Vice President of Vencor 400 West Market Street
Operating. Mr. Schweinhart's Louisville, KY 40202
principal occupation is Chief
Financial Officer and Senior Vice
President of Vencor
</TABLE>
(d) Each of the above listed directors and executive officers of Vencor and
Vencor Operating is a United States citizen.
<PAGE>
CUSIP No. 19652U 10 4 Page 8 of 9 Pages
(e) Neither Vencor, Vencor Operating nor any of their respective directors or
executive officers have, during the last five years, been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors), nor
are any of them been subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to, federal
or state securities laws or finding any violation with respect to such laws.
ITEM 3. SOURCE AND AMOUNTS OF FUNDS OR OTHER CONSIDERATION.
---------------------------------------------------
On October 27, 1998, the Reporting Persons exercised existing Director
Warrants issued by the Issuer to acquire 60,000 shares of the Issuer's Common
Stock for a total consideration of approximately $92,700. The Reporting Persons
used working capital to pay the consideration for this exercise.
ITEM 4. PURPOSE OF TRANSACTION.
-----------------------
Not Applicable.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
-------------------------------------
On November 3, 1998, the Reporting Persons completed the sale of 3,560,000
shares (the "Shares") of Common Stock of the Issuer. The Shares were sold
pursuant to a Registration Statement on Form S-3 filed by the Issuer which
became effective on November 3, 1998. The Reporting Persons received $6.375 per
share for the Shares which resulted in net proceeds of approximately $22 million
to the Reporting Persons.
The Reporting Persons ceased to be the beneficial owners of more than five
percent of the Common Stock on November 3, 1998. The Reporting Persons no
longer own beneficially any shares of Common Stock.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
---------------------------------------------------------------------
TO SECURITIES OF THE ISSUER.
- ----------------------------
Not Applicable.
<PAGE>
CUSIP No. 19652U 10 4 Page 9 of 9 Pages
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
---------------------------------
Exhibit No. Description Page No.
- ----------- ----------- --------
Exhibit 1 Joint Filing Agreement Previously
filed with the
Schedule 13D
dated April 30, 1998
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: November 23, 1998 VENCOR, INC.
By: /s/ W. Bruce Lunsford
----------------------------------
W. Bruce Lunsford, Chairman of the
Board and Chief Executive Officer
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: November 23, 1998 VENCOR OPERATING, INC.
By: /s/ W. Bruce Lunsford
----------------------------------
W. Bruce Lunsford, Chairman of the
Board and Chief Executive Officer
